Close Menu
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    StockNews24StockNews24
    Subscribe
    • Shares
    • News
      • Featured Company
      • News Overview
        • Company news
        • Expert Columns
        • Germany
        • USA
        • Price movements
        • Default values
        • Small caps
        • Business
      • News Search
        • Stock News
        • CFD News
        • Foreign exchange news
        • ETF News
        • Money, Career & Lifestyle News
      • Index News
        • DAX News
        • MDAX News
        • TecDAX News
        • Dow Jones News
        • Eurostoxx News
        • NASDAQ News
        • ATX News
        • S&P 500 News
      • Other Topics
        • Private Finance News
        • Commodity News
        • Certificate News
        • Interest rate news
        • SMI News
        • Nikkei 225 News1
    • Carbon Markets
    • Raw materials
    • Funds
    • Bonds
    • Currency
    • Crypto
    • English
      • العربية
      • 简体中文
      • Nederlands
      • English
      • Français
      • Deutsch
      • Italiano
      • Português
      • Русский
      • Español
    StockNews24StockNews24
    Home » Trump administration sued over Jan. 6 and health data
    Share

    Trump administration sued over Jan. 6 and health data

    userBy userFebruary 4, 2025No Comments3 Mins Read
    Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Email


    U.S. President Donald Trump looks on as he signs an executive order in the Oval Office at the White House in Washington, U.S., Jan. 31, 2025. 

    Carlos Barria | Reuters

    The Trump administration was sued Tuesday in separate civil complaints challenging a request for information about FBI employees who worked on cases involving President Donald Trump and the Jan. 6 Capitol riot, and the removal of data from federal health agency websites.

    The lawsuits are the latest in a growing number of legal salvos seeking to block — or slow down — the rapid-fire series of actions Trump and his allies have taken since he returned to the White House on Jan. 20.

    Both cases were filed in U.S. District Court in Washington, D.C.

    The first case, a class-action complaint, was filed by a group of nine unidentified FBI current and former agents, and employees of the agency against the Department of Justice.

    That suit seeks to block the publication or dissemination of information in surveys the plaintiffs or their supervisors have been ordered to fill out identifying “their specific role” in cases involving the Jan. 6, 2021, Capitol riot criminal cases, and the criminal prosecution of Trump himself for retaining classified records after leaving the White House in early 2021.

    The suit says that the survey was issued “to identify agents to be terminated or to suffer adverse employment action.”

    “Upon returning to the Presidency, Mr. Trump has ordered the DOJ to conduct a review and purge of FBI personnel involved in these investigations and prosecutions,” the suit says. “This directive is unlawful and retaliatory, and violates the Civil Service Reform Act.”

    The suit says the plaintiffs “reasonably fear that all or parts” of a list of FBI agents who worked on the Jan. 6 and Trump cases “might be published by allies of President Trump, thus placing themselves and their families in immediate danger of retribution by the now-pardoned and at-large Jan. 6 convicted felons.”

    The second lawsuit was filed by the advocacy group Doctors for America against the Office of Personnel Management, the Health and Human Services Department, the Centers for Disease Control and Prevention, and the Food and Drug Administration.

    That complaint challenges the abrupt removal last Friday from CDC and FDA websites “a broad range of health-related data and other information used every day by health professionals to diagnose and treat patients and by researchers to advance public health, including through clinical trials meant to establish the safety and efficacy of medical products.”

    This is breaking news. Please refresh for updates.



    Source link

    Share this:

    • Click to share on Facebook (Opens in new window) Facebook
    • Click to share on X (Opens in new window) X

    Like this:

    Like Loading...

    Related

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticleCEEZER Carbon Coalition Is Accepting Applications For Third Cohort
    Next Article DevvStream Joins Singapore Carbon Market Alliance To Advance Article 6-Aligned Carbon Credits
    user
    • Website

    Related Posts

    Asia markets live: Stocks rise

    April 9, 2025

    Amazon delays first Kuiper satellite launch due to bad weather

    April 9, 2025

    Trump says he does not want to see U.S. Steel go to Japan

    April 9, 2025
    Add A Comment

    Leave a ReplyCancel reply

    © 2025 StockNews24. Designed by Sujon.

    Type above and press Enter to search. Press Esc to cancel.

    %d